#generic-drug-competition

[ follow ]
Intellectual property law
fromMedCity News
3 days ago

Takeda Vows Appeal of $885M Jury Verdict in 'Pay-for-Delay' Antitrust Case - MedCity News

A jury awarded nearly $885 million against Takeda over a settlement that allegedly delayed generic competition for Amitiza, with potential trebling under federal antitrust law.
[ Load more ]